Amneal Pharmaceuticals Competitors and Similar CompaniesClear all

Amneal Pharmaceuticals's competitors and similar companies include Shionogi, Sagent Pharmaceuticals, Sun Pharma and Spirovant Sciences.

	Amneal Pharmaceuticals Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas.	Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.	Sagent Pharmaceuticals Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products.	Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.	Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
Founding Date	Founding Date 2002	Founding Date 1878	Founding Date 2006	Founding Date 1983	Founding Date 2016
Type	Type Public	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare distribution genetics pharma therapy	Tags Healthcare biotech drug development mental health pharma	Tags Healthcare Manufacturing & Industrial medical devices medtech	Tags Healthcare drug development pharma	Tags Healthcare genetics pharma therapy
Locations	Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more	Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more	Locations Schaumburg, US HQ	Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more	Locations Philadelphia, US HQ
Employees	Employees 8,1005% increase	Employees 4,955	Employees 2261% increase	Employees 43,000	Employees 234% decrease
Valuation ($)	Valuation ($) 2.6 b	Valuation ($) 12.3 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $3b (FY, 2025)	Revenue (est.) ¥499.7b (FY, 2026)	Revenue (est.) $318.3m (FY, 2015)	Revenue (est.) ₹582.2b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods $1.9b (FY, 2025)	Cost of goods ¥55.5b (FY, 2026)	Cost of goods $230.6m (FY, 2015)	Cost of goods ₹115.4b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit $1.1b (FY, 2025)	Gross profit ¥491.3b (FY, 2026)	Gross profit $87.7m (FY, 2015)	Gross profit ₹488.9b (FY, 2026)	Gross profit N/A
Net income	Net income $127.9m (FY, 2025)	Net income ¥205.9b (FY, 2026)	Net income ($21.9m) (FY, 2015)	Net income ₹115.6b (FY, 2026)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 4.7m	Total funding raised $ 70m	Total funding raised N/A	Total funding raised N/A